Case Number:

IPR2019-01398

Case Type:

IPR

Status:

Final Written Decision

Petitioner:

NOF CORPORATION

Patent Owner:

Nektar Therapeutics

Patent Number:

8273833

Tech Center:

1600

1. Filed: July 25, 2019 00:00

   Coverage

   1. August 02, 2021

      PTAB Axes Patent Claims For Nektar Hemophilia Drug

      The Patent Trial and Appeal Board has found that claims in two polymer patents that cover a hemophilia treatment developed by Nektar Therapeutics are obvious in light of a collection of prior art.

   1 other articles on this case. View all »

   ---

   Stay ahead of the curve

   In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.

   
   

   • Search PTAB cases and full-text documents.
   • Download filings with the U.S. Patent & Trademark Office’s Patent Trial & Appeal Board.
   • Set up alerts on new cases, follow ongoing cases, track new decisions and so much more!

   TRY LAW360 FREE FOR SEVEN DAYS

   View the PTAB case documents

   Already a subscriber? Click here to login